Medprin Regenerative Medical Technologies Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004NB8
CNY
45.16
-2.19 (-4.63%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Flat results in Mar 26

  • OPERATING PROFIT(Q) Lowest at CNY 21.57 MM
  • OPERATING PROFIT MARGIN(Q) Lowest at 27.52 %
  • PRE-TAX PROFIT(Q) Lowest at CNY 23.53 MM
2

With ROE of 13.27%, it has a expensive valuation with a 0.83 Price to Book Value

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 680 Million (Small Cap)

stock-summary
P/E

6.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.53%

stock-summary
Debt Equity

-0.37

stock-summary
Return on Equity

13.27%

stock-summary
Price to Book

0.83

Revenue and Profits:
Net Sales:
78 Million
(Quarterly Results - Mar 2026)
Net Profit:
21 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-26.87%
0%
-26.87%
6 Months
-35.08%
0%
-35.08%
1 Year
-21.77%
0%
-21.77%
2 Years
14.82%
0%
14.82%
3 Years
5.81%
0%
5.81%
4 Years
14.85%
0%
14.85%
5 Years
0%
0%
0.0%

Medprin Regenerative Medical Technologies Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
23.89%
EBIT Growth (5y)
47.20%
EBIT to Interest (avg)
35.56
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.41
Tax Ratio
14.29%
Dividend Payout Ratio
41.34%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.56%
ROE (avg)
8.17%

Valuation key factors

Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
0.83
EV to EBIT
3.54
EV to EBITDA
2.96
EV to Capital Employed
0.73
EV to Sales
1.02
PEG Ratio
0.28
Dividend Yield
1.53%
ROCE (Latest)
20.66%
ROE (Latest)
13.27%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 8.44% vs 26.40% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -14.46% vs 62.42% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "78.40",
          "val2": "72.30",
          "chgp": "8.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "21.60",
          "val2": "31.40",
          "chgp": "-31.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.20",
          "val2": "-0.60",
          "chgp": "133.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "20.70",
          "val2": "24.20",
          "chgp": "-14.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "275.20%",
          "val2": "335.00%",
          "chgp": "-5.98%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 32.25% vs 20.66% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 43.35% vs 92.91% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "364.60",
          "val2": "275.70",
          "chgp": "32.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "138.50",
          "val2": "102.50",
          "chgp": "35.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "1.20",
          "chgp": "-75.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.00",
          "val2": "-0.30",
          "chgp": "-566.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "113.10",
          "val2": "78.90",
          "chgp": "43.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "302.90%",
          "val2": "270.60%",
          "chgp": "3.23%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
78.40
72.30
8.44%
Operating Profit (PBDIT) excl Other Income
21.60
31.40
-31.21%
Interest
0.00
0.00
Exceptional Items
0.20
-0.60
133.33%
Consolidate Net Profit
20.70
24.20
-14.46%
Operating Profit Margin (Excl OI)
275.20%
335.00%
-5.98%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 8.44% vs 26.40% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -14.46% vs 62.42% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
364.60
275.70
32.25%
Operating Profit (PBDIT) excl Other Income
138.50
102.50
35.12%
Interest
0.30
1.20
-75.00%
Exceptional Items
-2.00
-0.30
-566.67%
Consolidate Net Profit
113.10
78.90
43.35%
Operating Profit Margin (Excl OI)
302.90%
270.60%
3.23%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 32.25% vs 20.66% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 43.35% vs 92.91% in Dec 2024

stock-summaryCompany CV
About Medprin Regenerative Medical Technologies Co., Ltd. stock-summary
stock-summary
Medprin Regenerative Medical Technologies Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available